Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection

Roche

Status: Completed

Conditions: HIV Infections

Study type: Observational

Funder types: Industry

Identifiers

NCT01297127

ML25398

Details and patient eligibility

About

This prospective observational study will evaluate predictors of response to Invirase (saquinavir) treatment in treatment-naïve patients with HIV infection. Data will be collected during 48 weeks of treatment.

Enrollment: 151 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients, >/= 18 years of age
• HIV infection
• Treatment-naïve
• Initiation of treatment with Invirase

Exclusion criteria

• Contraindications according to Invirase Summary of Product Characteristics

Trial design

151 participants in 1 patient group

Cohort